# FIGS Inc. (FIGS) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Biotechnology. Price $14.42, market value $2.4 billion.

## Valuation
- **P/E (trailing): 43.7×** (5-yr avg 122.1×, 3-yr avg 142.4×). FIGS Inc. trades at 43.7× trailing earnings, well below its own five-year average of 122.1×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 38.9×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.05**. A PEG of 0.05 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.4×**. Each dollar of revenue is priced at 3.4×.
- **Price / book: 5.4×**. The shares trade at 5.4× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 4.1%** (5-yr avg 2.7%). Free cash flow equals 4.1% of the market value, above its five-year average of 2.7%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 2.3%**. The inverse of the P/E: 2.3% of the price is earned each year.

## Profitability
- **Gross margin: 68.9%**. FIGS Inc. keeps 68.9% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 9.6%**. 9.6% of revenue is left after running the business.
- **Net margin: 5.4%**. 5.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.8%**. 7.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on assets: 10.7%**. Each dollar of assets produces 10.7% of profit.

## Growth
- **Revenue growth (1 yr): 13.6%** (3-yr 7.7%/yr, 5-yr 19.1%/yr). Revenue grew 13.6% over the last year, against 19.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 850.0%** (3-yr 20.0%/yr, 5-yr -8.7%/yr). Earnings per share rose 850.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Current ratio: 4.94** (quick 4.94). Current assets cover the next year's liabilities 4.94 times.
- **Altman Z-score: 13.18**. A Z-score of 13.18 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. FIGS Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 111.1%** (YTD 26.9%, 3-mo 21.5%). The shares are up 111.1% over twelve months including dividends.
- **From 52-week high: -17.5%** (121.8% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 0.90** (volatility 69%). Beta of 0.90 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=FIGS · Page: https://foliofundamentals.com/stocks/figs

Not investment advice.